Patterns of HIV-1 protein interaction identify perturbed host-cellular subsystems

PLoS Computational Biology

Volumn 6, Issue 7, 2010, Pages 2-

  MacPherson, Jamie I ^a   Dickerson, Jonathan E ^a   Pinney, John W ^b   Robertson, David L ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; GENE ONTOLOGY; PROTEINS;

CELL FUNCTIONS; CELLULAR SUBSYSTEMS; CURATION; HOST CELLS; HOST PROTEINS; HOSTS INTERACTIONS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PROTEINS; INTERACTION DATABASE; PROTEIN INTERACTION;

VIRUSES;

HUMAN IMMUNODEFICIENCY VIRUS 1 PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RNA POLYMERASE II; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNOREGULATION; INNATE IMMUNITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; T LYMPHOCYTE; TRANSCRIPTION REGULATION; VIRUS CELL INTERACTION; VIRUS REPLICATION; BIOLOGY; CLUSTER ANALYSIS; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; METHODOLOGY; PHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN DATABASE; REPRODUCIBILITY; SIGNAL TRANSDUCTION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; DATABASES, PROTEIN; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; PROTEIN INTERACTION MAPPING; REPRODUCIBILITY OF RESULTS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; VIRAL PROTEINS;

EID: 78049296111     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1000863     Document Type: Article

References (107)

1. Pinney J, Dickerson J, Fu W, Sanders-Beer B, Ptak R, et al. (2009) HIV-host interactions: a map of viral perturbation of the host system. AIDS 23: 549-554.
2. Dorr P, Westby M, Dobbs S, Griffin P, Irvine B, et al. (2005) Maraviroc (UK- 427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity. Antimicrobial Agents and Chemotherapy 49: 4721-4732.
3. Dyer M, Murali T, Sobral B (2008) The landscape of human proteins interacting with viruses and other pathogens. PLoS Pathogens 4: e32.
4. Ptak R, Fu W, Sanders-Beer B, Dickerson J, Pinney J, et al. (2008) Cataloguing the HIV Type 1 Human Protein Interaction Network. AIDS research and human retroviruses 24: 1497-1502.
5. Fu W, Sanders-Beer B, Katz K, Maglott D, Pruitt K, et al. (2009) Human immunodeficiency virus type 1, human protein interaction database at NCBI. Nucleic Acids Research 37: D417.
6. Rosario B, Hearst M (2005) Multi-way relation classification: application to protein-protein interactions. In: Proceedings of the article on Human Language Technology and Empirical Methods in Natural Language Processing, Association for Computational Linguistics Morristown, NJ, USA. pp 732-739.
7. Jabado N, Le Deist F, Fischer A, Hivroz C (1994) Interaction of HIV gp120 and anti-CD4 antibodies with the CD4 molecule on human CD4+ T cells inhibits the binding activity of NF-AT, NF-xB and AP-1, three nuclear factors regulating interleukin-2 gene enhancer activity. European journal of immunology 24: 2646-2652.
8. Brass A, Dykxhoorn D, Benita Y, Yan N, Engelman A, et al. (2008) Identification of host proteins required for HIV infection through a functional genomic screen. Science 319: 921-926.
9. König R, Zhou Y, Elleder D, Diamond T, Bonamy G, et al. (2008) Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135: 49-60.
10. Zhou H, Xu M, Huang Q, Gates A, Zhang X, et al. (2008) Genome-scale RNAi screen for host factors required for HIV replication. Cell Host & Microbe 4: 495-504.
11. Bushman F, Malani N, Fernandes J, D'Orso I, Cagney G, et al. (2009) Host Cell Factors in HIV Replication: Meta-Analysis of Genome-Wide Studies. PLoS Pathogens 5: e1000437.
12. MacPherson J, Pinney J, Robertson D (2009) JNets: Exploring networks by integrating annotation. BMC bioinformatics 10: 95.
13. Dunn B, Goodenow M, Gustchina A, Wlodawer A (2002) Retroviral proteases. Genome biology 3: 3006.
14. Ventoso I, Blanco R, Perales C, Carrasco L (2001) HIV-1 protease cleaves eukaryotic initiation factor 4G and inhibits cap-dependent translation. Proceedings of the National Academy of Sciences 98: 12966.
15. Nie Z, Bren G, Vlahakis S, Schimnich A, Brenchley J, et al. (2007) Human Immunodeficiency Virus Type 1 Protease Cleaves Procaspase 8 In Vivo. The Journal of Virology 81: 6947.
16. Perales C, Carrasco L, Ventoso I (2003) Cleavage of eIF4G by HIV-1 protease: effects on translation. FEBS letters 533: 89-94.
17. Alvarez E, Castelló A, Menéndez-Arias L, Carrasco L (2006) HIV protease cleaves poly (A)-binding protein. Biochemical Journal 396: 219.
18. Shaheduzzaman S, Krishnan V, Petrovic A, Bittner M, Meltzer P, et al. (2002) Effects of HIV-1 Nef on cellular gene expression profiles. Journal of Biomedical Science 9: 82-96.
19. Benson R, Sanfridson A, Ottinger J, Doyle C, Cullen B (1993) Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection. Journal of Experimental Medicine 177: 1561-1566.
20. Alonso A, Derse D, Peterlin B (1992) Human chromosome 12 is required for optimal interactions between Tat and TAR of human immunodeficiency virus type 1 in rodent cells. Journal of virology 66: 4617-4621.
21. Wei P, Garber M, Fang S, Fischer W, Jones K (1998) A novel CDK9- associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92: 451-462.
22. Zhou Q, Chen D, Pierstorff E, Luo K (1998) Transcription elongation factor PTEFb mediates Tat activation of HIV-1 transcription at multiple stages. The EMBO Journal 17: 3681-3691.
23. Ashburner M, Ball C, Blake J, Botstein D, Butler H, et al. (2000) Gene Ontology: tool for the unification of biology. Nature genetics 25: 25-29.
24. Pereira-Leal J, Levy E, Teichmann S (2006) The origins and evolution of functional modules: lessons from protein complexes. Philosophical Transactions B 361: 507.
25. Cicala C, Arthos J, Selig S, Dennis G, Hosack D, et al. (2002) HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication. Proceedings of the National Academy of Sciences 99: 9380.
26. Hakes L, Pinney J, Lovell S, Oliver S, Robertson D (2007) All duplicates are not equal: the difference between small-scale and genome duplication. Genome Biology 8: R209.
27. Mellor H, Parker P (1998) The extended protein kinase C superfamily. Biochemical Journal 332: 281-292.
28. Gupta S, Aggarwal S, Kim C, Gollapudi S (1994) Human immunodeficiency virus-1 recombinant gp 120 induces changes in protein kinase C isozymes. A preliminary report. International journal of immunopharmacology 16: 197-204.
29. Moore J, Kitchen S, Pugach P, Zack J (2004) The CCR5 and CXCR4 coreceptors-central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS research and human retroviruses 20: 111-126.
30. Simon M (2000) Receptor tyrosine kinases specific outcomes from general signals. Cell 103: 13-15.
31. Gordus A, Krall J, Beyer E, Kaushansky A, Wolf-Yadlin A, et al. (2009) Linear combinations of docking affinities explain quantitative differences in RTK signaling. Molecular Systems Biology 5: 235.
32. Mujtaba S, He Y, Zeng L, Farooq A, Carlson J, et al. (2002) Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain. Molecular cell 9: 575-586.
33. Jeang K, Xiao H, Rich E (1999) Multifaceted activities of the HIV-1 transactivator of transcription, Tat. Journal of Biological Chemistry 274: 28837-28840.
34. Bork P, Dandekar T, Diaz-Lazcoz Y, Eisenhaber F, Huynen M, et al. (1998) Predicting function: from genes to genomes and back. Journal of Molecular Biology 283: 707-725.
35. Linial M (2003) How incorrect annotations evolve-the case of short ORFs. Trends in Biotechnology 21: 298-300.
36. Gilks W, Audit B, De Angelis D, Tsoka S, Ouzounis C (2002) Modeling the percolation of annotation errors in a database of protein sequences. Bioinformatics 18: 1641.
37. Saitou N, Nei M (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Molecular biology and evolution 4: 406.
38. Chirmule N, Wang X, Hu R, Oyaizu N, Roifman C, et al. (1994) Envelope glycoproteins of HIV-1 interfere with T-cell-dependent B cell differentiation: role of CD4-MHC class II interaction in the effector phase of T cell help. Cellular immunology 155: 169.
39. Chirmule N, McCloskey T, Hu R, Kalyanaraman V, Pahwa S (1995) HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71). The Journal of Immunology 155: 917-924.
40. Cefai D, Debre P, Kaczorek M, Idziorek T, Autran B, et al. (1990) Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway. Journal of Clinical Investigation 86: 2117.
41. Hubert P, Bismuth G, Korner M, Debre P (1995) HIV-1 glycoprotein gp120 disrupts CD4-p56 lck/CD3-T cell receptor interactions and inhibits CD3 signaling. European journal of immunology 25: 1417-1425.
42. Schwartz O, Maréchal V, Le Gall S, Lemonnier F, Heard J (1996) Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nature Medicine 2: 338-342.
43. Benichou S, Benmerah A (2003) The HIV nef and the Kaposi-sarcomaassociated virus K3/K5 proteins: parasites of the endocytosis pathway. Médecine sciences: M/S 19: 100.
44. Madrid R, Janvier K, Hitchin D, Day J, Coleman S, et al. (2005) Nef-induced alteration of the early/recycling endosomal compartment correlates with enhancement of HIV-1 infectivity. Journal of Biological Chemistry 280: 5032-5044.
45. Michel N, Allespach I, Venzke S, Fackler O, Keppler O (2005) The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4. Current Biology 15: 714-723.
46. Venzke S, Michel N, Allespach I, Fackler O, Keppler O (2006) Expression of Nef downregulates CXCR4, the major coreceptor of human immunodeficiency virus, from the surfaces of target cells and thereby enhances resistance to superinfection. The Journal of Virology 80: 11141.
47. Chaudhry A, Das S, Jameel S, George A, Bal V, et al. (2007) A two-pronged mechanism for HIV-1 Nef-mediated endocytosis of immune costimulatory molecules CD80 and CD86. Cell Host & Microbe 1: 37-49.
48. Nel A, Hanekom C, Rheeder A, Williams K, Pollack S, et al. (1990) Stimulation of MAP-2 kinase activity in T lymphocytes by anti-CD3 or anti-Ti monoclonal antibody is partially dependent on protein kinase C. The Journal of Immunology 144: 2683-2689.
49. Nel A, Pollack S, Landreth G, Ledbetter J, Hultin L, et al. (1990) CD-3- mediated activation of MAP-2 kinase can be modified by ligation of the CD4 receptor. Evidence for tyrosine phosphorylation during activation of this kinase. The Journal of Immunology 145: 971-979.
50. Nel A, Hanekom C, Hultin L (1991) Protein kinase C plays a role in the induction of tyrosine phosphorylation of lymphoid microtubule-associated protein-2 kinase. Evidence for a CD3-associated cascade that includes pp56lck and that is defective in HPB-ALL. The Journal of Immunology 147: 1933-1939.
51. Gupta S, Weiss A, Kumar G, Wang S, Nel A (1994) The T-cell antigen receptor utilizes Lck, Raf-1, and MEK-1 for activating mitogen-activated protein kinase. Evidence for the existence of a second protein kinase Cdependent pathway in an Lck-negative Jurkat cell mutant. Journal of Biological Chemistry 269: 17349-17357.
52. Tian H, Lempicki R, King L, Donoghue E, Samelson L, et al. (1996) HIV envelope-directed signaling aberrancies and cell death of CD4+ T cells in the absence of TCR co-stimulation. International immunology 8: 65-74.
53. Phipps D, Read S, Piovesan J, Mills G, Branch D (1996) HIV infection in vitro enhances the activity of src-family protein tyrosine kinases. AIDS 10: 1191.
54. Shatrov V, Ratter F, Gruber A, Droge W, Lehmann V (1996) HIV type 1 glycoprotein 120 amplifies tumor necrosis factor-induced NF-kappa B activation in Jurkat cells. AIDS Res Hum Retroviruses 12: 1209-16.
55. Greenway A, Dutartre H, Allen K, McPhee D, Olive D, et al. (1999) Simian immunodeficiency virus and human immunodeficiency virus type 1 nef proteins show distinct patterns and mechanisms of Src kinase activation. Journal of virology 73: 6152-6158.
56. Witte V, Laffert B, Gintschel P, Krautkämer E, Blume K, et al. (2008) Induction of HIV transcription by Nef involves Lck activation and protein kinase C theta raft recruitment leading to activation of ERK1/2 but not NF kappa B. Journal of immunology (Baltimore, Md: 1950) 181: 8425.
57. Fackler O, Luo W, Geyer M, Alberts A, Peterlin B (1999) Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions. Molecular Cell 3: 729-739.
58. Marina V, Benedetta M, Francesca S, Elisabetta S, Luciana G, et al. (2003) HIV-1 Nef triggers Vav-mediated signaling pathway leading to functional and morphological differentiation of dendritic cells. Immunology letters 87: 191-192.
59. Varin A, Decrion A, Sabbah E, Quivy V, Sire J, et al. (2005) Synthetic Vpr protein activates activator protein-1, c-Jun N-terminal kinase, and NF-{kappa} B and stimulates HIV-1 transcription in promonocytic cells and primary macrophages. Journal of Biological Chemistry 280: 42557.
60. Pessler F, Cron R (2004) Reciprocal regulation of the nuclear factor of activated T cells and HIV-1. Genes and immunity 5: 158-167.
61. Malmgaard L (2004) Induction and regulation of IFNs during viral infections. Journal of interferon & cytokine research 24: 439-454.
62. di Somma M, Majolini M, Burastero S, Telford J, Baldari C (1996) Cyclosporin A sensitivity of the HIV-1 long terminal repeat identifies distinct p56lckdependent pathways activated by CD4 triggering. European journal of immunology 26: 2181-2188.
63. Macian F, Rao A (1999) Reciprocal modulatory interaction between human immunodeficiency virus type 1 Tat and transcription factor NFAT1. Molecular and Cellular Biology 19: 3645-3653.
64. Lahti A, Manninen A, Saksela K (2003) Regulation of T cell activation by HIV-1 accessory proteins: Vpr acts via distinct mechanisms to cooperate with Nef in NFAT-directed gene expression and to promote transactivation by CREB. Virology 310: 190-196.
65. Fenard D, Yonemoto W, de Noronha C, Cavrois M, Williams S, et al. (2005) Nef Is Physically Recruited into the Immunological Synapse and Potentiates T Cell Activation Early after TCR Engagement 1. The Journal of Immunology 175: 6050-6057.
66. Cicala C, Arthos J, Censoplano N, Cruz C, Chung E, et al. (2006) HIV-1 gp120 induces NFAT nuclear translocation in resting CD4+ T-cells. Virology 345: 105-114.
67. Hidalgo-Estévez A, González E, Punzón C, Fresno M (2006) Human immunodeficiency virus type 1 Tat increases cooperation between AP-1 and NFAT transcription factors in T cells. Journal of General Virology 87: 1603-1612.
68. Stacey A, Norris P, Qin L, Haygreen E, Taylor E, et al. (2009) Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. The Journal of Virology 83: 3719.
69. Gavioli R, Gallerani E, Fortini C, Fabris M, Bottoni A, et al. (2004) HIV-1 Tat Protein Modulates the Generation of Cytotoxic T Cell Epitopes by Modifying Proteasome Composition and Enzymatic Activity 1. The Journal of Immunology 173: 3838-3843.
70. Remoli A, Marsili G, Perrotti E, Gallerani E, Ilari R, et al. (2006) Intracellular HIV-1 Tat protein represses constitutive LMP2 transcription increasing proteasome activity by interfering with the binding of IRF-1 to STAT1. Biochem J 396: 371-380.
71. Varbanov M, Espert L, Biard-Piechaczyk M (2006) Mechanisms of CD4 T-cell depletion triggered by HIV-1 viral proteins. AIDS Rev 8: 221-236.
72. Lum J, Badley A (2003) Resistance to apoptosis: mechanism for the development of HIV reservoirs. Current HIV Research 1: 261-274.
73. Capaldi R (1990) Structure and function of cytochrome c oxidase. Annual Review of Biochemistry 59: 569-596.
74. Brazil D, Hemmings B (2001) Ten years of protein kinase B signalling: a hard Akt to follow. Trends in Biochemical Sciences 26: 657-664.
75. Pollard V, Malim M (1998) The HIV-1 rev protein. Annual Reviews in Microbiology 52: 491-532.
76. Neville M, Stutz F, Lee L, Davis L, Rosbash M (1997) The importin-beta family member Crm1p bridges the interaction between Rev and the nuclear pore complex during nuclear export. Current Biology 7: 767-775.
77. Yi R, Bogerd H, Cullen B (2002) Recruitment of the Crm1 nuclear export factor is sufficient to induce cytoplasmic expression of incompletely spliced human immunodeficiency virus mRNAs. Journal of virology 76: 2036-2042.
78. Stutz F, Izaurralde E, Mattaj I, Rosbash M (1996) A role for nucleoporin FG repeat domains in export of human immunodeficiency virus type 1 Rev protein and RNA from the nucleus. Molecular and cellular biology 16: 7144-7150.
79. Zolotukhin A, Felber B (1999) Nucleoporins nup98 and nup214 participate in nuclear export of human immunodeficiency virus type 1 Rev. Journal of virology 73: 120-127.
80. Chook Y, Blobel G (2001) Karyopherins and nuclear import. Current Opinion in Structural Biology 11: 703-715.
81. Sherman M, Greene W (2002) Slipping through the door: HIV entry into the nucleus. Microbes and infection 4: 67-73.
82. Agostini I, Popov S, Li J, Dubrovsky L, Hao T, et al. (2000) Heat-shock protein 70 can replace viral protein R of HIV-1 during nuclear import of the viral preintegration complex. Experimental Cell Research 259: 398-403.
83. Christ F, Thys W, De Rijck J, Gijsbers R, Albanese A, et al. (2008) Transportin-SR2 imports HIV into the nucleus. Current Biology 18: 1192-1202.
84. Krishnan L, Matreyek K, Oztop I, Lee K, Tipper C, et al. (2010) The Requirement for Cellular Transportin 3 (TNPO3 or TRN-SR2) during Infection Maps to Human Immunodeficiency Virus Type 1 Capsid and Not Integrase. The Journal of Virology 84: 397.
85. Bieniasz P (2006) Late budding domains and host proteins in enveloped virus release. Virology 344: 55-63.
86. Kino T, Pavlakis G (2004) Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1. DNA and cell biology 23: 193-205.
87. Brady J, Kashanchi F (2005) Tat gets the "green" light on transcription initiation. Retrovirology 2: 69.
88. Vanegas M, Llano M, Delgado S, Thompson D, Peretz M, et al. (2005) Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering. Journal of cell science 118: 1733.
89. Llano M, Saenz D, Meehan A, Wongthida P, Peretz M, et al. (2006) An essential role for LEDGF/p75 in HIV integration. Science 314: 461.
90. Kanehisa M, Goto S (2000) KEGG: Kyoto encyclopedia of genes and genomes. Nucleic acids research 28: 27.
91. Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita K, Itoh M, et al. (2006) From genomics to chemical genomics: new developments in KEGG. Nucleic acids research 34: D354.
92. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, et al. (2008) KEGG for linking genomes to life and the environment. Nucleic acids research 36: D480.
93. Ford E, Puronen C, Sereti I (2009) Immunopathogenesis of asymptomatic chronic HIV Infection: the calm before the storm. Current Opinion in HIV and AIDS 4: 206.
94. Goila-Gaur R, Strebel K (2008) HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology 5: 51.
95. Lehner T, Wang Y, Pido-Lopez J, Whittall T, Bergmeier L, et al. (2008) The emerging role of innate immunity in protection against HIV-1 infection. Vaccine 26: 2997-3001.
96. Barr S, Smiley J, Bushman F (2008) The interferon response inhibits HIV particle production by induction of TRIM22. PLoS Pathogens 4: e1000007.
97. Tokarev A, Skasko M, Fitzpatrick K, Guatelli J (2009) Antiviral activity of the interferon-induced cellular protein BST-2/tetherin. AIDS research and human retroviruses 25: 1197-1210.
98. Dickerson J, Pinney J, Robertson D (2010) The biological context of HIV-1 host interactions reveals subtle insights into a system hijack. BMC Systems Biology 4: 80.
99. Bandyopadhyay S, Kelley R, Ideker T (2006) Discovering regulated networks during HIV-1 latency and reactivation. In: Pacific Symposium on Biocomputing Pacific Symposium on Biocomputing. pp 354-366.
100. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B Methodological 57: 289.
101. Prelic A, Bleuler S, Zimmermann P, Wille A, Buhlmann P, et al. (2006) A systematic comparison and evaluation of biclustering methods for gene expression data. Bioinformatics 22: 1122-1129.
102. Stark C, Breitkreutz B, Reguly T, Boucher L, Breitkreutz A, et al. (2006) BioGRID: a general repository for interaction datasets. Nucleic acids research 34: D535.
103. Bader G, Donaldson I, Wolting C, Ouellette B, Pawson T, et al. (2001) BIND-the biomolecular interaction network database. Nucleic acids research 29: 242.
104. Peri S, Navarro J, Kristiansen T, Amanchy R, Surendranath V, et al. (2004) Human protein reference database as a discovery resource for proteomics. Nucleic acids research 32: D497.
105. Smith T, Waterman M (1981) Identification of common molecular subsequences. Journal of Molecular Biology 147: 195-197.
106. Jiang J, Conrath D (1997) Semantic similarity based on corpus statistics and lexical taxonomy. arXiv:cmp-lg/9709008v1.
107. Shannon P, Markiel A, Ozier O, Baliga N, Wang J, et al. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome research 13: 2498-2504.